The Best Chance at Beating Breast Cancer

WEST LAFAYETTE, Ind. - Oct. 21, 2013 - PRLog -- How a new cancer-screening test takes out the guesswork

Now the most common form of cancer in women worldwide, each one of usprobably knows a friend or loved one that has been affected by breast cancer or even experienced it ourselves.  In the U.S. alone, breast cancer takes over 40,000 lives annually, and though we all know that early detection is the key, it sometimes seems that the route to breast cancer diagnosis is riddled with a multitude of tests that don’t always offer definitive answers.

Identifying breast cancer is typically a multi-step process.  The early steps are subjective and the later steps can be invasive.  With increasing proactivity about personal health, oncologists have seen a sharp increase in women seeking breast cancer screenings. The good news is that this gives way to early stage breast cancer detection and a fuller spectrum of options for treatment. But unfortunately, it often takes several different screenings, including biopsies, in order to confirm positive breast cancer diagnosis.

Looking forward into the future of cancer treatment, these screenings still lack the simplicity and accuracy of a true and definitive diagnosis.

A new, diagnostic tool on the market today is a test called the ONCOblot®. The ONCOblot® Test is a single blood test that can detect a breast cancer of 2 million cells as opposed to the 4.5 trillion cells necessary in a positive mammogram diagnosis. The ONCOblot® Test virtually eliminates any subjective analysis of diagnosis and can be used in conjunction with other current tests/screenings prior to a biopsy.

A non-invasive test that detects breast cancer even in early development is a valuable new tool for us all.  And, what makes ONCOblot® even more valuable, is that it detects over 26 forms of cancer.

The ONCOblot® Test doesn’t have the power to eliminate the cancer, but it does have the power to give patients more time, options, and definitive answers along their care continuum.

To learn more about the ONCOblot® Test, visit www.oncoblotlabs.com.